ZA9510108B - Composition and method for prevention and treatment of HIV-1 infection - Google Patents

Composition and method for prevention and treatment of HIV-1 infection

Info

Publication number
ZA9510108B
ZA9510108B ZA9510108A ZA9510108A ZA9510108B ZA 9510108 B ZA9510108 B ZA 9510108B ZA 9510108 A ZA9510108 A ZA 9510108A ZA 9510108 A ZA9510108 A ZA 9510108A ZA 9510108 B ZA9510108 B ZA 9510108B
Authority
ZA
South Africa
Prior art keywords
hiv
infection
prevention
treatment
composition
Prior art date
Application number
ZA9510108A
Other languages
English (en)
Inventor
Jan Maria Rene Balzarini
Original Assignee
Rega Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rega Inst filed Critical Rega Inst
Publication of ZA9510108B publication Critical patent/ZA9510108B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9510108A 1994-11-30 1995-11-28 Composition and method for prevention and treatment of HIV-1 infection ZA9510108B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/346,721 US5968910A (en) 1994-11-30 1994-11-30 Compositions containing two or three inhibitors of different HIV reverse transcriptases

Publications (1)

Publication Number Publication Date
ZA9510108B true ZA9510108B (en) 1996-06-06

Family

ID=23360750

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510108A ZA9510108B (en) 1994-11-30 1995-11-28 Composition and method for prevention and treatment of HIV-1 infection

Country Status (16)

Country Link
US (1) US5968910A (es)
EP (1) EP0794793B1 (es)
JP (1) JP3655636B2 (es)
KR (1) KR100403545B1 (es)
CN (1) CN1104909C (es)
AU (1) AU717025B2 (es)
BR (1) BR9509925A (es)
CA (1) CA2204652C (es)
DE (1) DE69535366T2 (es)
HU (1) HU223548B1 (es)
IL (1) IL115944A (es)
MX (1) MX9704024A (es)
NZ (1) NZ297006A (es)
RU (1) RU2227750C2 (es)
WO (1) WO1996016675A2 (es)
ZA (1) ZA9510108B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696151A (en) * 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
WO1999008110A1 (en) * 1997-08-08 1999-02-18 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
CN1192102C (zh) 1998-01-23 2005-03-09 新生物生物公司 酶催化的治疗剂
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
CN1391486A (zh) 1999-07-22 2003-01-15 新生物公司 治疗对治疗有抗性的肿瘤的方法
WO2001021160A2 (en) * 1999-09-23 2001-03-29 Axxima Pharmaceuticals Aktiengesellschaft Carboxymide and aniline derivatives as selective inhibitors of pathogens
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
CN101108178B (zh) * 2006-07-20 2010-09-15 复旦大学 一种亲环素a抑制剂在制备抗艾滋病药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268389A (en) * 1989-10-16 1993-12-07 Uniroyal Chemical Company, Inc. Thiocarboxylate ester compounds compositions containing the same
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
ATE138928T1 (de) * 1991-09-04 1996-06-15 Stichting Rega V Z W Substituierte nukleosidderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
IL115944A (en) 2001-10-31
CA2204652C (en) 2009-04-07
EP0794793A1 (en) 1997-09-17
DE69535366D1 (de) 2007-02-22
BR9509925A (pt) 1997-09-30
KR987000088A (ko) 1998-03-30
US5968910A (en) 1999-10-19
JPH10500996A (ja) 1998-01-27
IL115944A0 (en) 1996-05-14
AU717025B2 (en) 2000-03-16
NZ297006A (en) 2001-03-30
CA2204652A1 (en) 1996-06-06
HU223548B1 (hu) 2004-09-28
KR100403545B1 (ko) 2004-05-27
EP0794793B1 (en) 2007-01-10
CN1167442A (zh) 1997-12-10
MX9704024A (es) 1998-02-28
HUT77573A (hu) 1998-06-29
JP3655636B2 (ja) 2005-06-02
WO1996016675A2 (en) 1996-06-06
AU4176996A (en) 1996-06-19
DE69535366T2 (de) 2007-10-11
CN1104909C (zh) 2003-04-09
RU2227750C2 (ru) 2004-04-27
WO1996016675A3 (en) 1996-08-29

Similar Documents

Publication Publication Date Title
EP0758242A4 (en) COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS (CMV) INFECTIONS
AU2103195A (en) Device and method for treatment of dentition
ZA941860B (en) Halogen compositions for water treatment and method of preparation thereof
AP9300598A0 (en) Compositions and method for waste treatment
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
IL106640A0 (en) Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor
ZA9810788B (en) Method and composition for the treatment and prevention of hyperuricemia
AU3681095A (en) Method and pharmaceutical composition for prevention and treatment of brain damage
AU2180097A (en) Composition for prevention and treatment of periodontal diseases
EP0975654A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS
AU5157998A (en) Methods and compositions for treatment of hepatitis c infection
ZA9510108B (en) Composition and method for prevention and treatment of HIV-1 infection
GB9014307D0 (en) Method of treatment and compositions therefor
IL116925A (en) Combinations of compounds useful for treating HIV infections and pharmaceutical compositions comprising these combinations
GB2343844B (en) Composition and method for treatment of hypertrophic skin accumlations and their prevention
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
GB9419571D0 (en) Treatment of oral infections
AU3762397A (en) Treatment and prevention of helicobacter infection
GB9625398D0 (en) Method of treatment,manufacture,compositions and compounds
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
AU7176496A (en) Composition and method of treating retroviral infection
AU2609195A (en) Treatment and prevention of helicobacter infection
GB9608927D0 (en) Method of treatment and pharmaceutical composition
GB9414652D0 (en) Method of treatment